Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/28/2025

Diagnostic and Risk‑Assessment Strategies for Recurrent Cerebrovascular Accident (CVA)

Immediate Neuroimaging

  • Perform non‑contrast CT or MRI of the brain as soon as possible to confirm acute ischemic disease and differentiate recurrent stroke from hemorrhagic transformation or mimics. [1][2]
  • Complete brain imaging within 24 hours of presentation; earlier imaging shortens time to definitive therapy. [3][1]
  • Use non‑contrast CT as the first‑line test to exclude intracranial hemorrhage and to identify ischemic changes. [4][1]5
  • Prefer MRI with DWI/FLAIR sequences when available, because it is more sensitive than CT for small infarcts and posterior‑circulation strokes. 5
  • If the initial scan does not show a symptomatic infarct, obtain a follow‑up MRI to confirm diagnosis and to predict early‑stroke risk. [1][2]

Vascular Imaging (Concurrent with Brain Imaging)

  • Obtain non‑invasive cervical and intracranial vascular imaging (CTA or MRA) within 24 hours to identify arterial stenosis, occlusions, or other mechanisms. [3][1]
  • Perform CTA from the aortic arch to the vertex (or equivalent MRA) to screen for large‑vessel disease and guide treatment decisions. [1][2]
  • For patients with anterior‑circulation symptoms who may be candidates for revascularization, acquire carotid imaging (ultrasound, CTA, or MRA). [1][2]
  • Intracranial large‑artery imaging is recommended to detect atherosclerosis, arterial dissection, or moyamoya disease. [1][2]

Laboratory Evaluation (Do Not Delay Imaging)

  • Order routine laboratory tests within 48 hours, but do not postpone neuroimaging while awaiting results. 1
  • Include complete blood count, prothrombin time, and partial thromboplastin time. [1][2]
  • Measure glucose (or HbA1c) and renal function (creatinine). [1][2]
  • Obtain a fasting or non‑fasting lipid profile. [1][2]
  • For patients on warfarin, verify INR before thrombolysis; otherwise, proceed with imaging and treatment without waiting for labs. 4

Cardiac Evaluation in Cryptogenic Stroke

  • Perform transthoracic echocardiography (with or without contrast) as an initial cardiac assessment. [1][2]
  • Consider transesophageal echocardiography, cardiac CT, or cardiac MRI when embolic stroke of undetermined source (ESUS) is suspected. [1][2]
  • Implement long‑term rhythm monitoring (e.g., mobile cardiac outpatient telemetry or implantable loop recorder) to detect intermittent atrial fibrillation. [1][2]

Clinical Features Signifying Highest Early Recurrence Risk

  • Patients presenting within 48 hours of symptom onset, with unilateral motor weakness or speech disturbance, have a 3–6 % risk of stroke in the first 1–4 weeks and up to a 24 % concurrent‑stroke detection rate on MRI. [6][3]

Silent Brain Infarction

Population Proportion with Silent Infarction on DWI‑MRI
Patients with acute retinal or cerebral artery occlusion 19 % – 25 %
  • Silent infarctions identified on DWI‑MRI confer a high risk for subsequent clinical stroke and warrant prompt referral to a stroke center, even if overt neurological deficits are absent. 6

Limitations of CT‑Only Imaging

  • Relying solely on CT within the first 24 hours may miss up to 24 % of concurrent cerebrovascular accidents in patients with retinal artery occlusion; DWI‑MRI is required for detection. 6

Comprehensive Cardiovascular Risk Assessment

  • Conduct a full cardiovascular risk evaluation for every patient with recurrent CVA. 7
  • Review history of coronary heart disease (myocardial infarction, angina, arrhythmias, heart failure). 7
  • Calculate 10‑year coronary heart disease risk using Framingham algorithms. 7
  • Patients with a ≥20 % 10‑year CHD risk or significant carotid disease should be considered for non‑invasive cardiac testing. 7

Approach to a Patient with Past History of Stroke

Initial Assessment

  • The American Heart Association recommends establishing the time the patient was last known well, obtaining a focused vascular risk factor history, performing the NIH Stroke Scale (NIHSS) for neurological assessment, and measuring blood pressure to determine acute management decisions and risk stratification 8, 9
  • Documenting the exact time the patient was last at baseline or symptom-free is crucial, and creative questioning with time anchors can help establish onset 8, 10

History Taking

  • The American College of Cardiology recommends assessing cardiovascular disease history, including myocardial infarction, angina, cardiac arrhythmias, congestive heart failure, valvular surgery, pacemaker, and peripheral arterial disease 8, 11
  • Cerebrovascular history, including prior stroke or transient ischemic attack (TIA), carotid endarterectomy, should be evaluated 8, 11
  • Metabolic conditions, such as diabetes mellitus, hypertension, and hyperlipidemia, should be assessed 8, 11

Physical Examination

  • Blood pressure measurement is critical, and hypertension is common in acute ischemic stroke patients 8, 9
  • The NIH Stroke Scale (NIHSS) is the standard for measuring stroke severity and functional improvement, and provides prognostic information and influences acute treatment decisions 8, 9, 12

Neurological Examination

  • A focused neurological assessment, including level of consciousness, focal neurological deficits, cranial nerve examination, motor movements, reflexes, and Babinski signs, should be performed 11, 13, 14
  • The American Academy of Neurology recommends assessing vision and hearing 11

Ruling Out Stroke Mimics

  • Common conditions that mimic stroke, such as postseizure state (Todd's paralysis), brain neoplasm, migraine with aura, hypoglycemia, seizures, and psychogenic disorders, must be excluded quickly 8, 9, 10

Critical Pitfalls to Avoid

  • The American Heart Association recommends not delaying thrombolytic therapy waiting for laboratory results unless there is clinical suspicion of bleeding abnormality, thrombocytopenia, or the patient has received heparin/warfarin 8, 9
  • Elevated blood pressure should not be treated aggressively unless diastolic BP >120 mmHg or systolic BP >220 mmHg in non-thrombolytic candidates 8, 9

Additional Assessments

  • A behavioral assessment using tools like the Neuropsychiatric Inventory-Q, depression screening with scales such as CES-D or Geriatric Depression Scale, and functional assessment using Pfeffer Functional Assessment Questionnaire or Barthel Index should be performed 11
  • A 12-lead ECG should be performed due to the high incidence of cardiac disease in stroke patients, and cardiac enzyme tests can screen for myocardial ischemia 15, 12

REFERENCES

15

Initial Assessment and Management of Acute Stroke in Young Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025